Pixium Vision (PXMVF) Stock Price, News & Analysis

Company Overview

Pixium Vision S.A. was a France-based medical technology company focused on developing bionic vision systems for people with severe or profound vision loss. Its work combined implantable retinal devices, external cameras and image-processing technology to provide artificial visual perception.

The company’s principal product candidate was the Prima System, a photovoltaic subretinal implant designed for patients with geographic atrophy associated with dry age-related macular degeneration. Pixium also developed the IRIS retinal implant, which was intended for certain patients with retinitis pigmentosa and other degenerative retinal diseases. Its technologies were evaluated through clinical studies in Europe and the United States.

Pixium Vision was founded in 2011 and was headquartered in Paris, France. The company subsequently experienced financial difficulties and entered judicial liquidation proceedings in France, ending its activities as an operating medical-device developer. Its securities have continued to be referenced in over-the-counter markets under the symbol PXMVF.

Key Stats

• Today's Range: C$0.03 to C$1.50
• 50-Day Range: C$0.03 to C$0.03
• 52-Week Range: C$0.03 to C$0.03
• Volume: N/A
• Average Volume: 8,800 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:PXMVF
• CIK: N/A
• Web: www.pixium-vision.com
• Phone: 33 1 76 21 47 68
• Fax: N/A
• Employees: 40
• Year Founded: 2011

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A